Back to Search
WILLIAM HAIRE, MD
MD
Hematology & Oncology Physician
NPI: 1225086929Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
17326(NE)
Research & Publications (13)
Recombinant urokinase for restoration of patency in occluded central venous access devices. A double-blind, placebo-controlled trial.
PMID 15351854·Thromb Haemost·2004
3-trial
Multiple organ dysfunction syndrome in hematopoietic stem cell transplantation.
PMID 12004245·Crit Care Med·2002
6-review
Techniques in dosing for thrombolysis of occluded central venous catheters.
PMID 11981800·Tech Vasc Interv Radiol·2001
8-other
Venous thromboembolic disease. NCCN. Clinical practice guidelines in oncology.
PMID 18926086·J Natl Compr Canc Netw·2008
6-review
Pancytopenia due to iron deficiency worsened by iron infusion: a case report.
PMID 18067664·J Med Case Rep·2007
8-other
Hematopoietic stem cell transplantation for Hodgkin's disease in a patient with dysfibrinogenemia and thrombosis.
PMID 17131175·J Thromb Thrombolysis·2007
5-case
Venous thromboembolic disease. Clinical practice guidelines in oncology.
PMID 17020664·J Natl Compr Canc Netw·2006
6-review
Recombinant urokinase is safe and effective in restoring patency to occluded central venous access devices: a multiple-center, international trial.
PMID 15483405·Crit Care Med·2004
3-trial
The clinical thrombosis center and clinical thrombologist: a new US health systems paradigm for the management of venous thromboembolic disease.
PMID 14739633·J Thromb Thrombolysis·2003
8-other
Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism.
PMID 12932312·Curr Hematol Rep·2003
3-trial
Organ dysfunction following stem cell transplantation: relationship to plasma cytokine concentrations.
PMID 11781651·Bone Marrow Transplant·2001
3-trial
Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo-controlled trial--the Cardiovascular Thrombolytic to Open Occluded Lines (COOL) efficacy trial.
PMID 11487675·J Vasc Interv Radiol·2001
3-trial
Central nervous system dysfunction as the first manifestation of multiple organ dysfunction syndrome in stem cell transplant patients.
PMID 10654019·Bone Marrow Transplant·2000
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 988095 NEBRASKA MEDICAL CTR
OMAHA, NE 68198 - Phone
- (402) 559-9800
Quick Facts
- NPI
- 1225086929
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 13
Are you this provider?
Claim Your Profile